GlassScriptPhysician profile
Henry M Alba
NPI 1770695017
$1,444.67
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $43.26 · 2021: $1,041 · 2022: $148 · 2023: $58.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,000.00 | 2021 | |
| Fidia Pharma USA INC. | $89.56 | 2019-2022 | |
| Lilly USA, LLC | $81.68 | 2019-2023 | Emgality, Reyvow |
| Abbvie INC. | $57.68 | 2021-2022 | |
| Pacira Therapeutics, INC. | $46.52 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $33.05 | 2019 | |
| Pfizer INC. | $32.59 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $25.77 | 2020 | |
| Nevro Corp. | $24.31 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.32 | 2022 | |
| Lundbeck LLC | $15.85 | 2023 | Vyepti |
| Vertical Pharmaceuticals, LLC | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Alba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.